Few anatomical tools hold more potential to revolutionize the science of diagnostics than biomarkers, and pathologists and medical laboratories will be first in line to put these powerful tools to use helping patients with chronic diseases There’s good news for both anatomic pathology … [Read more...]
From Micro-hospitals to Mobile ERs: New Models of Healthcare Create Challenges and Opportunities for Pathologists and Medical Laboratories
New low-cost alternatives to emergency department and hospital visits could require flexibility from pathology groups and clinical laboratories to provide the best quality care In response to the rising cost of conventional hospital services, innovative healthcare models such as micro-hospitals, … [Read more...]
Clinical Laboratory Companies, Hospitals, and Other Providers Preparing to Comply with FASB’s ‘ASC 606–Revenue Recognition Standard’
All medical laboratory companies and hospitals following GAAP must comply as early as 2018 and 2019; revenue and profit impact can be either beneficial or negative There is a big change coming to clinical laboratory companies, hospitals, and other providers that report their organization’s … [Read more...]
WannaCry Ransomware Holds Critical Data Hostage Worldwide, Including UK’s National Health Service and Russia’s Interior Ministry
Attack on computer systems worldwide highlights critical importance for hospitals and medical laboratories to regularly update IT infrastructure and software While Internet connectivity and automation are changing the landscape of both healthcare and diagnostic testing facilities, it is also … [Read more...]
Bundled Payments for Joint Replacements Cuts Costs for Medicare; Hospitals Held Accountable for Quality of Care
Clinical laboratories must stay informed about the success of bundled-payment initiatives because they will need to negotiate a share of these payments where medical laboratory testing is involved Research published this year concluded that bundled payments for joint replacement services performed … [Read more...]
Trends in Genomic Research That Could Impact Clinical Laboratories and Anatomic Pathology Groups Very Soon
Genomics is quickly becoming the foundational disruptor technology on which many new and powerful clinical laboratory tests and procedures will be based Genomics testing has become accessible, affordable, and in some instances, life-saving. Clinical laboratories and pathology groups are handling … [Read more...]
New Chinese Paper-Based Test That Reveals Blood Type in Mere Seconds with 99.9% Accuracy Could Impact Medical Laboratories in the US
Low-cost assay would be a boon in remote areas, war zones, and emergency departments by providing fast and reliable blood typing without the need for specialized clinical lab equipment, and by reducing demand on type-O blood supplies Chinese researchers claim to have invented an inexpensive … [Read more...]
Crowdsourced Medicine Could Provide Pathologists and Medical Laboratory Scientists with New Methods for Helping Physicians Diagnose Rare Medical Conditions
Unorthodox approach could one day provide clinical laboratories with new market opportunities to offer patients diagnostic services Patients turning to the Internet to learn about medical ailments, chronic disease, medical laboratory tests, or pathology treatments is nothing remarkable these days. … [Read more...]
Pathology Groups and Clinical Laboratories Have Unique Opportunity to Take Leadership Role in Healthcare Consumerism
Medical laboratories are in key position to advise and guide other healthcare organizations to implementing strategies and technologies that support consumerism in healthcare Dark Daily has regularly alerted our readers to the fact that employers and healthcare policymakers are seeking ways for … [Read more...]
Federal Judges Block Anthem-Cigna and Aetna-Humana Deals to Protect Market Competition and Healthcare Consumers
Mergers that would have reshaped the nation’s largest insurance companies would directly affect the provider networks independent medical laboratories rely on For pathology groups and medical laboratories, the news about two thwarted deals involving mega insurance companies might be seen as a … [Read more...]
